Clinical trials reveal that 10% to 15% of patients taking GLP-1 medications are considered "non-responders," losing less than ...

Check out the latest Regeneron Pharmaceuticals Inc. (REGN) stock quote and chart. View real-time stock prices & the company’s financial overview to help with your trading & investment.

A new documentary explores the impact of Esther Wojcicki, celebrated Palo Alto educator and "Godmother of Silicon Valley." ...

The GLP-1 weight loss drugs revolutionizing the treatment of obesity, diabetes and a slew of other diseases come with a major ...

In a study, people with gene variants in two genes lost slightly more weight on GLP-1 drugs, but threw up more on Zepbound.

Study of almost 28,000 people also identifies genetic variants that raise the risk of gastrointestinal side effects from ...

Changes in two genes appear to help predict whether patients will lose substantial weight on GLP-1 drugs — and whether the ...

New 23andMe Research Institute study, published in Nature,  identifies genetic predictors for GLP-1 weight loss efficacy and ...

In October 2023, 23andMe confirmed that a hacker had accessed the genetic profiles of nearly 7 million people through a months-long credential stuffing attack. The information exposed was unlike ...

Shelly’s dad died in a 1984 plane crash. That chapter of her life closed. Then she took a 23andMe test that found three surprise sisters. But is the DNA truth or a fraud? Plus the FCC bans ...

Originally from the northwest suburbs, Emily K. Coleman is Shaw Media's editor for newsletters and engagement. She previously served as the Northwest Herald's editor and spent about seven years as a ...

Reconstructed Ancestors sets a new industry standard to help reveal deeper family connections and fill gaps in a family tree with greater precision. This collection of features underscores 23andMe’s ...